CMS Open Payments · Tool
Otsuka Pharmaceutical Development & Commercialization, Inc. vs Roche Diagnostics Operations, Inc.
Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.
A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.
Compare Different Companies
Payment Overview
- Total Payments
- $14.8M
- % of Industry
- 0.1%
- Transactions
- 5,037
- Avg per Transaction
- $2.9K
- Recipients
- 4,515
- Avg per Recipient
- $3.3K
- Payment Types
- 7
- Top Payment Type
- Consulting Fee
Roche Diagnostics Operations, Inc.
- Total Payments
- $14.9M
- % of Industry
- 0.1%
- Transactions
- 1,269
- Avg per Transaction
- $11.7K
- Recipients
- 0
- Avg per Recipient
- $0.00
- Payment Types
- 0
- Top Payment Type
- -
Highlighted values indicate the higher figure for each metric.
Total payments compared
Otsuka Pharmaceutical Development & Commercialization, Inc. vs Roche Diagnostics Operations, Inc. - total reported payments in CMS Open Payments PY2024
General Payment Types Breakdown
Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.
Otsuka Pharmaceutical Development & Commercialization, Inc.
83.3%
4.8%
4.3%
4.1%
3.2%
0.2%
Roche Diagnostics Operations, Inc.
No payment type data available.
Top 5 General-Payment Recipients
This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.
Otsuka Pharmaceutical Development & Commercialization, Inc.
- 1
BRUCE BERGER
$458,120.30 · 28 txns
- 2
LINDA CAPPIELLO-LINDSLEY
$349,301.30 · 8 txns
- 3
HASSAN MALIK
$253,953.54 · 14 txns
- 4
MARYAM SABA
$166,680.00 · 9 txns
- 5
HAOLING WENG
$155,309.11 · 6 txns
Roche Diagnostics Operations, Inc.
No recipient data available.
Summary Comparison
| Metric | Otsuka Pharmaceutical Development & Commercialization, Inc. | Roche Diagnostics Operations, Inc. |
|---|---|---|
| Total Payments | $14.8M | $14.9M |
| % of Industry Total | 0.1% | 0.1% |
| Transaction Count | 5,037 | 1,269 |
| Avg per Transaction | $2.9K | $11.7K |
| Recipient Count | 4,515 | 0 |
| Avg per Recipient | $3.3K | $0.00 |
| Payment Type Count | 7 | 0 |
| Top Payment Type | Consulting Fee | - |
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.